CXCL10 and tuberculosis: These data show that IP-10 down-regulation, in response to TB treatment, is more pronounced in TB+HIV− patients when compared to TB+HIV+ patients, suggesting that sustained viral replication possibly contributes to elevated concentrations of IP-10 in HIV infected TB patients.